1108960

Bioreliance Ltd. — FEI 3005343934

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 27, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Glasgow (United Kingdom)